Orion Pharma and Novartis Launch First Parkinson's Disease Study to Explore Potential of Delaying Dyskinesia with Stalevo®
September 07, 2004 02:06 ET
|
Orion Oyj
Orion Pharma and Novartis intend to launch a major study in Parkinson's disease seeking to demonstrate that, when used as initial therapy, the optimized levodopa medication Stalevo - containing...
Brit Insurance Holdings PLC Announces Interim Results for the Six Months Ending 30 June 2004
September 07, 2004 02:03 ET
|
Brit Insurance Holdings PLC
LONDON, U.K., Sept. 7, 2004 (PRIMEZONE) -- Brit Insurance Holdings PLC, the UK general insurance group, today announces interim results for the six months ending 30 June 2004.
Highlights
- ...
Orion käynnistää Novartiksen kanssa suuren tutkimusohjelman Parkinson-potilailla
September 07, 2004 02:00 ET
|
Orion Oyj
Orion Pharma ja sen yhteistyökumppani Novartis käynnistävät syyskuussa suuren kansainvälisen potilastutkimuksen selvittääkseen, voidaanko uudella, Orion Pharman kehittämällä...
LAF237, first in a new class of oral antidiabetic agents, shown in phase II to provide clinically significant improvement in glycemic control
September 07, 2004 02:00 ET
|
Novartis Pharma AG
LAF237, first in a new class of oral antidiabetic agents, shown in phase II to provide clinically significant improvement in glycemic controlResearchers conclude LAF237 positively influences both...
Nokia to enable BlackBerry Connect Solution on Series 80 mobile devices
September 07, 2004 01:56 ET
|
Nokia Oyj
Symbian OS-based BlackBerry connectivity expected on Nokia 9500 Communicator during Q1 2005
NEW YORK - September 7, 2004-Nokia (NYSE: NOK), the world leader in mobile communications, today...
JetBlue Resumes Florida Service Following Hurricane Frances
September 06, 2004 14:06 ET
|
JetBlue Airways Corporation
NEW YORK, Sept. 6, 2004 (PRIMEZONE) -- JetBlue Airways (Nasdaq:JBLU) has resumed service between New York's John F Kennedy, Boston's Logan and Washington's Dulles and LA's Long Beach airports and its...
Fair value as of August 31, 2004
September 06, 2004 12:00 ET
|
Private Equity Holding AG
The fair value (intrinsic value) of one registered share of Private Equity Holding AG stood at EUR 34.27 (CHF 52.85) as of August 31, 2004.
The development of the fair value, share price and...
Fair value as of August 31, 2004
September 06, 2004 12:00 ET
|
Private Equity Holding AG
The fair value (intrinsic value) of one registered share of Private Equity Holding AG stood at EUR 34.27 (CHF 52.85) as of August 31, 2004.
The development of the fair value, share price and...
Fair Value per 31. August 2004
September 06, 2004 12:00 ET
|
Private Equity Holding AG
Der Fair Value (innerer Wert) einer Namenaktie der Private Equity Holding AG per 31. August 2004 betrug EUR 34.27 (CHF 52.85).
Die untenstehende Aufstellung zeigt die Entwicklung des Fair...
Fair Value per 31. August 2004
September 06, 2004 12:00 ET
|
Private Equity Holding AG
Der Fair Value (innerer Wert) einer Namenaktie der Private Equity Holding AG per 31. August 2004 betrug EUR 34.27 (CHF 52.85).
Die untenstehende Aufstellung zeigt die Entwicklung des Fair...
- January 10, 2025 16:05 ET Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 31, 2024
- January 10, 2025 16:00 ET WhiteBIT TR and Misyon Bank Sign Agreement